New Production Facility Created by Teva in Debrecen

The pharmaceutical firm Teva Gyógyszergyár Plc. has built a new, specialized production facility in Debrecen worth more than USD 2 million (HUF 673.6 million). The significance of the investment is increased by the fact that the development of the product manufactured in the facility was also carried out by researchers in Debrecen, the company told MTI on Thursday.

It said that the new production facility will produce an immunosuppressant product vital for organ transplant patients.

According to the statement, years of development are coming together in a project just completed at Teva Pharmaceuticals in Debrecen. More than a decade ago, the company handed over its so-called High Containment plant for the production of high potency products.

In January this year, a new, specialized production area was started at the plant, which has a production capacity of EUR one billion, with the aim of bringing an important finished product from the Debrecen site's portfolio to even more patients, using the highest safety standards and complex technical solutions.

“The importance of the investment and the importance of the research base of the Debrecen site is underlined by the fact that in recent years two research disciplines have been working on the development of the product," the statement said.